Perrigo Company plc Ordinary Shares’s Trend Up, Especially After This Options Activity

 Perrigo Company plc Ordinary Shares's Trend Up, Especially After This Options Activity

In today’s session Perrigo Company plc Ordinary Shares (PRGO) registered an unusually high (610) contracts volume of call trades. Someone, most probably a professional was a very active buyer of the November, 2016 call, expecting serious PRGO increase. With 610 contracts traded and 2194 open interest for the Nov, 16 contract, it seems this is a quite bullish bet. The option with symbol: PRGO161118C00085000 closed last at: $3.3 or 0% . About 336,527 shares traded hands. Perrigo Company plc Ordinary Shares (NYSE:PRGO) has declined 29.96% since April 11, 2016 and is downtrending. It has underperformed by 36.11% the S&P500.

Perrigo Company plc Ordinary Shares (NYSE:PRGO) Ratings Coverage

Out of 14 analysts covering Perrigo Company Plc (NYSE:PRGO), 4 rate it a “Buy”, 1 “Sell”, while 9 “Hold”. This means 29% are positive. $241 is the highest target while $84 is the lowest. The $132.91 average target is 48.55% above today’s ($89.47) stock price. Perrigo Company Plc has been the topic of 33 analyst reports since October 23, 2015 according to StockzIntelligence Inc. As per Monday, June 20, the company rating was downgraded by Argus Research. B. Riley & Co downgraded Perrigo Company plc Ordinary Shares (NYSE:PRGO) rating on Friday, February 19. B. Riley & Co has “Neutral” rating and $146 price target. The stock has “Equal-Weight” rating given by Morgan Stanley on Thursday, December 3. The stock of Perrigo Company plc Ordinary Shares (NYSE:PRGO) earned “Buy” rating by B. Riley & Co on Tuesday, November 24. The stock has “Buy” rating given by B. Riley & Co on Wednesday, November 18. Barclays Capital maintained Perrigo Company plc Ordinary Shares (NYSE:PRGO) on Tuesday, April 26 with “Overweight” rating. BTIG Research downgraded the stock to “Neutral” rating in Monday, April 25 report. Barclays Capital initiated Perrigo Company plc Ordinary Shares (NYSE:PRGO) on Thursday, January 21 with “Overweight” rating. Goldman Sachs downgraded the stock to “Sell” rating in Monday, February 22 report. The company was downgraded on Monday, April 25 by Wells Fargo.

According to Zacks Investment Research, “Perrigo Company plc develops, manufactures and distributes healthcare products. The company operates primarily in four segments: Consumer Healthcare, Nutritionals, Rx Pharmaceutical and Active Pharmaceutical Ingredients. It also provides animal health products. The company operates primarily in the United States, the United Kingdom, Mexico, Israel, Australia, Canada, China and Latin America. Perrigo Company plc formerly known as Perrigo Company is headquartered in Ireland.”

Insitutional Activity: The institutional sentiment decreased to 0.81 in Q2 2016. Its down 0.38, from 1.19 in 2016Q1. The ratio is negative, as 103 funds sold all Perrigo Company plc Ordinary Shares shares owned while 175 reduced positions. 80 funds bought stakes while 146 increased positions. They now own 96.70 million shares or 9.76% less from 107.16 million shares in 2016Q1.
Calvert Mgmt has 0.04% invested in the company for 9,148 shares. Norris Perne French Llp Mi owns 25,050 shares or 0.49% of their US portfolio. Davis R M last reported 0.79% of its portfolio in the stock. Driehaus Capital Limited Com holds 17,439 shares or 0.06% of its portfolio. Cambridge Investment Research Advsr Incorporated accumulated 0.01% or 3,911 shares. The Pennsylvania-based Coho Prtn has invested 0.04% in Perrigo Company plc Ordinary Shares (NYSE:PRGO). Capital Guardian Trust holds 260 shares or 0% of its portfolio. Timber Hill Ltd Liability Corporation holds 0.01% of its portfolio in Perrigo Company plc Ordinary Shares (NYSE:PRGO) for 15,136 shares. Moreover, Goelzer Investment has 0.26% invested in Perrigo Company plc Ordinary Shares (NYSE:PRGO) for 21,103 shares. Barbara Oil Company last reported 3,000 shares in the company. Deere And holds 0.03% or 6,444 shares in its portfolio. The New York-based Pointstate Ltd Partnership has invested 0.18% in Perrigo Company plc Ordinary Shares (NYSE:PRGO). Segall Bryant & Hamill Ltd Liability Company owns 32,405 shares or 0.08% of their US portfolio. Tiaa Cref Inv Mngmt Ltd Co accumulated 477,867 shares or 0.03% of the stock. First Niagara Financial Bank has invested 0.09% of its portfolio in Perrigo Company plc Ordinary Shares (NYSE:PRGO).

PRGO Company Profile

Perrigo Company plc (Perrigo), formerly Perrigo Company Limited, incorporated on June 28, 2013, is an over-the-counter (OTC) consumer goods and specialty pharmaceutical company. The Company’s divisions include Consumer Healthcare (CHC), Branded Consumer Healthcare (BCH), Prescription Pharmaceuticals (Rx), Specialty Sciences and Other. The Firm makes OTC healthcare products and supplies infant formulas for the store brand market. It is also a well-known provider of generic extended topical prescription products. It provides healthcare products across a range of product categories and geographies, primarily in North America, Europe and Australia, as well as in other markets, including Israel and China.

More recent Perrigo Company plc Ordinary Shares (NYSE:PRGO) news were published by: Fool.com which released: “Why Perrigo Company PLC Ordinary Shares Are Dropping Today” on April 25, 2016. Also Fool.com published the news titled: “Why Perrigo Company PLC Ordinary Shares Are Plummeting Today” on February 18, 2016. Investorplace.com‘s news article titled: “3 Stocks to Watch Monday: Tesla Motors Inc (TSLA), Perrigo Company plc …” with publication date: September 12, 2016 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Tags: , ,

Related posts

Leave a Comment